The eIg technology to generate Ig-like bispecific antibodies

Bispecific antibodies have emerged as therapeutic molecules with a multitude of modes of action and applications. Here, we present a novel approach to solve the light-chain problem for the generation of bispecific Ig-like antibodies using the second constant domain of IgE (EHD2) genetically modified...

Full description

Bibliographic Details
Main Authors: Lennart Kühl, Nadine Aschmoneit, Roland E. Kontermann, Oliver Seifert
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:mAbs
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2022.2063043